Preservation of Quality of Life in HER2+ Metastatic Breast Cancer Patients Treated with Tucatinib or Placebo when Added to Trastuzumab and Capecitabine (The HER2CLIMB Trial)

Autor: Müller, Volkmar, Wardley, Andrew, Paplomata , Elizavet, Hamilton, Erika, Zelnak, Amelia, Fehrenbacher, Louis, Jakobsen, Erik, Curtit, Elsa, Boyle, Frances, Harder Brix, Eva, Brenner, Andrew, Crouzet, Laurence, Ferrario, Cristiano, Muñoz-Mateu, Montserrat, Arkenau, Tobias, Iqbal, Nayyer, Aithal, Sramila, Block, Margaret, Cold, Soeren, Cancel, Mathilde, Hahn, Olwen, Poosarla, Teja, Stringer-Reasor, Erica, Colleoni, Marco, Cameron, David A, Curigliano, Giuseppe, Siadek, Muriel, DeBusk, Kendra, Ramos, Jorge, Feng, Wentao, Gelmon, Karen

Publikováno v: Müller, V, Wardley, A, Paplomata, E, Hamilton, E, Zelnak, A, Fehrenbacher, L, Jakobsen, E, Curtit, E, Boyle, F, Harder Brix, E, Brenner, A, Crouzet, L, Ferrario, C, Muñoz-Mateu, M, Arkenau, T, Iqbal, N, Aithal, S, Block, M, Cold, S, Cancel, M, Hahn, O, Poosarla, T, Stringer-Reasor, E, Colleoni, M, Cameron, D A, Curigliano, G, Siadek, M, DeBusk, K, Ramos, J, Feng, W & Gelmon, K 2021, ' Preservation of Quality of Life in HER2+ Metastatic Breast Cancer Patients Treated with Tucatinib or Placebo when Added to Trastuzumab and Capecitabine (The HER2CLIMB Trial) ', European Journal of Cancer . https://doi.org/10.1016/j.ejca.2021.05.025

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3094::3b1ebd47b08ed3fd033a17c5ef8b00d9
https://hdl.handle.net/20.500.11820/c35bddf6-027d-473a-b36c-3c4a853660a5